Find comprehensive information on Methamphetamine Use Disorder diagnosis, including clinical documentation, ICD-10-CM codes (F15.10, F15.11, F15.19, F15.90), DSM-5 criteria, screening tools, and treatment resources for healthcare professionals. Learn about methamphetamine intoxication, withdrawal, psychotic disorder, and effective medical coding practices for accurate reimbursement. This resource supports clinicians in proper identification, documentation, and billing related to Methamphetamine Use Disorder.
Also known as
Methamphetamine-related disorders
Covers various methamphetamine use disorders.
Other stimulant-related disorders
Includes stimulant use disorders not otherwise specified.
Amphetamine-related disorders
Covers various amphetamine use, including dependence.
Tobacco use
Often co-occurs with methamphetamine use disorder.
When to use each related code
| Description |
|---|
| Methamphetamine dependence and abuse. |
| Stimulant Use Disorder (NOS) |
| Other (or Unknown) Substance Use Disorder |
Coding F15.10 without specifying current use, continuous use, or early remission creates audit risks and impacts reimbursement.
Failure to capture co-occurring mental health (e.g., anxiety, psychosis) or physical conditions impacts severity and care planning.
Miscoding acute intoxication (F15.129) as methamphetamine use disorder (F15.10) leads to inaccurate data and claims.
Patient presents with signs and symptoms consistent with Methamphetamine Use Disorder (Stimulant Use Disorder, Meth Abuse, Meth Addiction). The patient reports a pattern of methamphetamine use leading to clinically significant impairment or distress, as manifested by at least two of the following criteria within a 12-month period: methamphetamine is often taken in larger amounts or over a longer period than was intended; there is a persistent desire or unsuccessful efforts to cut down or control methamphetamine use; a great deal of time is spent in activities necessary to obtain, use, or recover from the effects of methamphetamine; craving, or a strong desire or urge to use methamphetamine; recurrent methamphetamine use resulting in a failure to fulfill major role obligations at work, school, or home; continued methamphetamine use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of methamphetamine; important social, occupational, or recreational activities are given up or reduced because of methamphetamine use; recurrent methamphetamine use in situations in which it is physically hazardous; methamphetamine use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by methamphetamine; tolerance, as defined by either a need for markedly increased amounts of methamphetamine to achieve intoxication or desired effect or a markedly diminished effect with continued use of the same amount of the substance; withdrawal, as manifested by either the characteristic withdrawal syndrome for methamphetamine or methamphetamine is taken to relieve or avoid withdrawal symptoms. Severity specifier: (Specify Mild, Moderate, or Severe based on the number of criteria met). Differential diagnoses considered included other substance use disorders, mood disorders, and psychotic disorders. Assessment includes a comprehensive psychosocial history, mental status examination, and laboratory testing as indicated (e.g., urine drug screen). Treatment plan recommendations include individual andor group therapy, cognitive behavioral therapy (CBT), contingency management, motivational interviewing, andor medication-assisted treatment options. Patient education provided regarding the risks associated with methamphetamine use, relapse prevention strategies, and available community resources. Follow-up appointment scheduled to monitor progress and adjust treatment as needed. ICD-10-CM diagnosis code: F15.10.